LA JOLLA, Calif., Feb. 17, 2021 /PRNewswire/ -- Avidity
Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company
pioneering a new class of oligonucleotide-based therapies called
Antibody Oligonucleotide Conjugates (AOCs™), today
announced that Sarah Boyce,
President and Chief Executive Officer, and Art Levin, Ph.D., Chief Scientific Officer, will
participate in a fireside chat at the 10th Annual SVB Leerink
Global Healthcare Conference on Wednesday,
February 24th, 2021 at 2:00pm PST. The conference is being held in a
virtual format.
A live webcast of the virtual fireside chat will be available on
the Company's website at www.aviditybiosciences.com in the
Investors section. A replay of the fireside chat will be archived
on the site for 90 days.
About Avidity Biosciences
Avidity Biosciences, Inc. is
pioneering a new class of oligonucleotide-based therapies called
AOCs designed to overcome the current limitations of
oligonucleotide therapies in order to treat a wide range of serious
diseases. Avidity utilizes its proprietary AOC platform to design,
engineer and develop therapeutics that combine the tissue
selectivity of monoclonal antibodies and the precision of
oligonucleotide therapies in order to access previously undruggable
tissue and cell types and more effectively target underlying
genetic drivers of diseases. Avidity's lead
product candidate, AOC 1001, is designed to treat myotonic
dystrophy type 1, and its four other muscle programs are focused on
the treatment of facioscapulohumeral muscular dystrophy, Duchenne
muscular dystrophy, muscle atrophy and Pompe disease. In addition
to its muscle franchise, Avidity has research efforts focused on
immune and other cell types.
Avidity is headquartered in La Jolla, CA. For more
information about our science, pipeline and people, please
visit www.aviditybiosciences.com and engage with us
on LinkedIn.
Contacts:
Company:
Mike MacLean
(858) 401-7900
mikemaclean@aviditybio.com
Media and Investors:
Cherise Adkins
Spectrum Science
(202) 587-2507
cadkins@spectrumscience.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/avidity-biosciences-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference-301229158.html
SOURCE Avidity Biosciences, Inc.